Publications
Peer-reviewed evidence behind the platform
Aqtual's peer-reviewed and preprint work.
Type
Area
Showing 26 of 26
Every program here runs on the same active-chromatin cfDNA platform.
See how it worksA blood-based test to inform treatment selection.
Most RA patients cycle through therapies before finding one that works. Aqtual's blood test reads synovial-associated active-chromatin signal to help match each patient to the right treatment class from the start.
Aqtual's peer-reviewed and preprint work.